Acrospire Investment Management’s Tobira Therapeutics, Inc. Common Stock TBRA Stock Holding History

Acrospire Investment Management’s Portfolio TBRA Stock Details TBRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-105	Closed	-$4K	–	2601
2016 Q3	$4K	Buy	+105	New	+$1.17K	﹤0.01%	1869

Acrospire Investment Management's TBRA Position: Q4 2016 in Review

Acrospire Investment Management sold out of Tobira Therapeutics, Inc. Common Stock (TBRA) in Q4 2016, closing a stake of 105 shares — an estimated $4K sold.

Acrospire Investment Management first reported a position in TBRA in Q3 2016 and held it in 1 quarter. The position peaked at $4K in Q3 2016. 0 funds tracked by Wall St. Rank hold TBRA as of Q4 2016.

Acrospire Investment Management reported no remaining Tobira Therapeutics, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
Acrospire Investment Management sold 105 Tobira Therapeutics, Inc. Common Stock shares in Q4 2016, an estimated $4K.
Acrospire Investment Management first reported a position in Tobira Therapeutics, Inc. Common Stock in Q3 2016 and held it in 1 quarter.
Acrospire Investment Management's Tobira Therapeutics, Inc. Common Stock position peaked at $4K in Q3 2016.
0 funds tracked by Wall St. Rank held Tobira Therapeutics, Inc. Common Stock as of Q4 2016.

Based on Acrospire Investment Management's 13F filing for Q4 2016, filed 14 Feb 2017.